Related Experiment Videos
G2 checkpoint control: checking in to the last resort for DNA damage
Jeffrey R Jackson1, Bin-Bing Zhou
1Department of Molecular and Cellular Oncology, GlaxoSmithKline, Collegeville, Pennsylvania, USA. jeffrey.r.jackson@gsk.com
Cancer Biology & Therapy
|March 9, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin.
ACS medicinal chemistry letters·2014
Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295.
ACS medicinal chemistry letters·2014
Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab.
Cancer immunology, immunotherapy : CII·2012
An immune-active tumor microenvironment favors clinical response to ipilimumab.
Cancer immunology, immunotherapy : CII·2011
The molecular mechanisms of platelets in tumor invasion and metastasis: a controversial role.
Cancer biology & therapy·2026
Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics.
Cancer biology & therapy·2026
DNA polymerase theta (Polθ): a novel candidate for targeted cancer therapy.
Cancer biology & therapy·2026
Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer.
Cancer biology & therapy·2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin.
Cancer biology & therapy·2026
Implementing emerging customer screening standards for nucleic acid synthesis.
Frontiers in bioengineering and biotechnology·2026
Dead-time Correction for High-count-rate WDS Analysis in Electron Probe Microanalysis.
Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2026
Specific cleavage of 5' overhangs of non-target strand by Cas9 activated by target DNA binding.
Nucleic acids research·2026